CH391L/S2013 Taylor Pursell Feb 27 2013: Difference between revisions
(New page: [http://www.ncbi.nlm.nih.gov/pubmed/23352430 Identification of Early Replicating Fragile Sites that Contribute to Genome Instability.] Barlow JH, Faryabi RB, Callén E, Wong N, Malhowski A...) |
|||
| Line 2: | Line 2: | ||
==Background== | ==Background== | ||
===Replication and Fragile Sites=== | |||
The eukaryotic genome is divide into regions which are programmed to replicate at different times during S-phase of the cell cycle. Gene products important to the cell, or active genes, are replicated in the first half of s-phase, or are associated with early replication, while inactive genes are replicated during the second half of S-phase and are associated with late replication site firing [2]. | |||
Chromosomal fragile sites which are specific stretched of genetic material that are prone to gaps and breaks following replication leading to chromosome instability; these fragile sites are put into two classes: rare and common fragile sites. Rare fragile sites are those found in only a few individuals and are usually associated with genetic disorders (e.g. Fragile X syndrome) while '''common fragile sites''' (CFS) are found in all individuals [3]. Common fragile sites are can be associated with large genes, large AT rich regions, and stalled DNA replication [1,3]. | |||
===B-Lymphocytes and DNA Damage=== | |||
B-lymphocytes, or B-cells, originate in the bone marrow where their maturation occurs. Large B-cells circulated in the blood and become activated once an antigen binds to their surface receptor. Once activated, large B-cells undergo rapid proliferation and genomic rearrangements [1,4]. These genome changes come in two classes: | |||
1) '''somatic hypermutation'''(SHM) in which point mutations are induced in the variable region of immunoglobulin (Ig) genes and | |||
2) '''class switch recombination''' (CSR) where one constant region of Ig is deleted and replaced with another[1]. | |||
An enzyme celled activation-induced cytidine deaminase (AID) initiates these genome changes by deaminating cytosine residues on ssDNA that are exposed during Ig transcription. Although this is its primary function it is not uncommon for it to cause other DNA damage specifically to oncogenes like c-Myc [1]. | |||
==Introduction== | ==Introduction== | ||
Revision as of 00:03, 24 February 2013
Identification of Early Replicating Fragile Sites that Contribute to Genome Instability. Barlow JH, Faryabi RB, Callén E, Wong N, Malhowski A, Chen HT, Gutierrez-Cruz G, Sun HW, McKinnon P, Wright G, Casellas R, Robbiani DF, Staudt L, Fernandez-Capetillo O, Nussenzweig A. Cell. 2013 Jan 22. pii: S0092-8674(13)00008-1.
Background
Replication and Fragile Sites
The eukaryotic genome is divide into regions which are programmed to replicate at different times during S-phase of the cell cycle. Gene products important to the cell, or active genes, are replicated in the first half of s-phase, or are associated with early replication, while inactive genes are replicated during the second half of S-phase and are associated with late replication site firing [2].
Chromosomal fragile sites which are specific stretched of genetic material that are prone to gaps and breaks following replication leading to chromosome instability; these fragile sites are put into two classes: rare and common fragile sites. Rare fragile sites are those found in only a few individuals and are usually associated with genetic disorders (e.g. Fragile X syndrome) while common fragile sites (CFS) are found in all individuals [3]. Common fragile sites are can be associated with large genes, large AT rich regions, and stalled DNA replication [1,3].
B-Lymphocytes and DNA Damage
B-lymphocytes, or B-cells, originate in the bone marrow where their maturation occurs. Large B-cells circulated in the blood and become activated once an antigen binds to their surface receptor. Once activated, large B-cells undergo rapid proliferation and genomic rearrangements [1,4]. These genome changes come in two classes: 1) somatic hypermutation(SHM) in which point mutations are induced in the variable region of immunoglobulin (Ig) genes and 2) class switch recombination (CSR) where one constant region of Ig is deleted and replaced with another[1].
An enzyme celled activation-induced cytidine deaminase (AID) initiates these genome changes by deaminating cytosine residues on ssDNA that are exposed during Ig transcription. Although this is its primary function it is not uncommon for it to cause other DNA damage specifically to oncogenes like c-Myc [1].
